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Abstract We examined the in£uence of Ser/Ala190 in the S1
site on P1 substrate selectivity in several serine proteases. The
impact of residue 190 on the selectivity was constant, regardless
of di¡erences in original selectivity or reactivity. Substrate bind-
ing in S1 was optimised in all wild-type enzymes, while the
e¡ects on kcat depended on the combination of residue 190
and substrate. Mutagenesis of residue 190 did not a¡ect the
S2^S4 sites. Pronounced selectivity for arginine residues was
coupled with low enzymatic activity, in particular in recombi-
nant factor IXa. This is due to the dominance of the S1^P1
interaction over substrate binding in the S2^S4 sites.
, 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
All trypsin-like serine proteases share a substrate preference
for a basic P1 residue, lysine or arginine. This is mainly
caused by the presence of a negatively charged Asp189 at
the bottom of the S1 pocket (chymotrypsinogen numbering
used throughout) [1]. The architecture of the S1 site within
these proteases is highly conserved [2]. One marked di¡erence
is localised to position 190, which is either serine or alanine,
and serves as a ¢ngerprint of the enzyme subfamilies. Signi¢-
cantly, the enzymes of the blood coagulation cascade di¡er in
this position. The executioners of the cascade, thrombin and
factor Xa, have Ala190, whereas the physiologic activators of
factor X, factor VIIa and factor IXa, have serine conserved at
position 190 through di¡erent species [3,4].
This observation poses the question whether Ser/Ala190
translates into the di¡erent substrate speci¢city of these en-
zymes and whether this di¡erence a¡ects substrate residues in
addition to the P1 residue. The P1 residue of almost all phys-
iologic substrates of the coagulation factors VIIa, IXa, Xa
and thrombin is arginine [5]. In the absence of the physiolog-
ical protein cofactor and substrate, factor VIIa and in partic-
ular factor IXa are very poor enzymes [6,7]. This property
might also be linked to the primary speci¢city of these en-
zymes.
From a structural point of view, the binding of arginine
into the S1 site di¡ers from lysine as only the former is able
to form a direct ionic interaction with Asp189, while the in-
teraction of the shorter lysine side chain to Asp189 is water-
bridged [8]. Ser190 is positioned in the S1 pocket to allow an
additional hydrogen bond to a bound lysine or arginine, thus
stabilising either of the substrate residues [9,10].
We considered the various S1^P1 interactions as a binary
2U2 matrix with the enzyme having either serine or alanine at
position 190 and the substrate having either arginine or lysine
at P1. To systematically investigate this simpli¢ed system, we
introduced point mutations at position 190 (AlaHSer) in the
coagulation factors rf9a (Ser190) and rf10a (Ala190), trypsin
(Ser190), and rXY (Ser190), a hybrid containing the N-termi-
nal subdomain of factor Xa and the C-terminal subdomain of
trypsin (wild-type residue is given in parentheses) [11]. For
each of these four proteases we kinetically analysed both the
wild-type and the appropriate mutant enzyme using commer-
cially available para-nitroanilide (pNA) substrates.
2. Materials and methods
2.1. Chemicals
All synthetic substrates were purchased from Roche Diagnostics
(Mannheim, Germany) and Chromogenix (Mo«lndal, Sweden). All
other materials were of the highest grade commercially available.
2.2. Construction and production of recombinant proteins
All wild-type and mutant proteins were from human species and
produced according to previously published procedures [11^13]. Tryp-
sin denotes the predominant pancreatic trypsin I isoform.
2.3. Amidolytic assays and determination of kinetic parameters
Experiments were performed in 50 mM Tris, 150 mM NaCl, 5 mM
CaCl2, 0.1% PEG 8000, pH 8.0 at 25‡C in a temperature-controlled
Kontron-Uvikon 933 spectrophotometer (Kontron Instruments, Mi-
lan, Italy). Enzyme concentrations were between 1 and 1000 nM.
Seven di¡erent substrate concentrations of a two-fold dilution series
were used. Depending on the substrate and enzyme, the starting con-
centrations of the substrate ranged between 0.5 and 10 mM. Reac-
tions were started by adding the enzyme to the pre-warmed reaction
bu¡er. The change in absorption at 405 nm was monitored for typi-
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cally 2 min and vE/min was calculated from the linear part of the
curve with a correlation coe⁄cient of the linear regression s 0.99.
Kinetic parameters were calculated by non-linear curve ¢tting of the
initial rates to the Michaelis^Menten equation using the SigmaPlot
software (Jandel, Erkrath, Germany) and an extinction coe⁄cient for
pNA of O405 = 9920 M31 cm31.
3. Results and discussion
3.1. Biochemical characterisation of the impact of Ser/Ala190
on the amidolytic activity of rTry, rXYa, rf10a
The kinetic parameters kcat, Km and kcat/Km were deter-
mined for rTry, rXYa, rf10a and the respective mutants in
position 190 using a series of commercially available pNA
peptide substrates (Table 1). The majority of these substrates
had an arginine in P1 and di¡ered in P2^P4. Two substrate
pairs di¡ered in P1 (lysine versus arginine), while the other
residues were identical.
3.2. Mutagenesis of position 190 does not change the selectivity
pro¢le of S2^S4 in rTry, rXYa and rf10a
It cannot be excluded that mutations in S1 have long-dis-
tance e¡ects on S2^S4. Precedents for analogous long-range
dependences of substrate speci¢city and reactivity are found in
several proteases (e.g. [13,14]). We therefore examined the
in£uence of the S1 site mutation in position 190 on the sub-
strate selectivity in S2^S4 to test for such long-distance e¡ects.
This was performed by comparison of the reactivity of the
mutant and wild-type enzymes with a series of substrates
that were identical in P1 (arginine) but di¡ered in S2^S4 (Ta-
ble 2). In particular, we looked for every enzyme at its nor-
malised activity pro¢le, which is independent of the absolute
reactivities and is thus better suited for comparison.
The activity with P1^arginine substrates was decreased in
all mutants to about half the original value. The changes in
activity were in a similar range, as re£ected by similar kcat/KM
ratios in Table 2, irrespective of the di¡erences in overall
reactivity with the substrates that spanned two orders of mag-
nitude. The conservation of the activity pro¢le between wild-
type and mutant enzymes indicates that mutagenesis of resi-
due 190 does not in£uence the other binding sites. Otherwise,
alteration of the S2^S4 sites would lead to changed substrate
preferences and cause a modi¢ed activity pro¢le with the sub-
strates that are identical in P1 but di¡er in P2^P4. This ¢nd-
ing was also con¢rmed by comparison of the crystal structures
of rXYa and rXYa-S190A, where no conformational rear-
rangement in the S2^S4 sites was observed [15].
3.3. Position 190 has a comparable in£uence on the selectivity
for P1-Arg/-Lys side chains in rTry, rXYa, rf10a and rf9a
We examined the in£uence of serine and alanine 190 on the
selectivity for arginine and lysine substrate side chains in the
S1 site of rTry, rXYa, rf10a and rf9a using two substrate pairs
(tGPR and tGPK; VLR and VLK) (Table 3).
The substrate pair VLX (X=R/K) was hydrolysed approx-
imately 10-fold less e⁄ciently than tGPX by the enzyme pairs
rTry, rXYa and rf10a. The selectivity for arginine was higher
with VLX in these enzymes. The reactivity of rf9a was several
orders of magnitude lower than in the other enzymes but did
not di¡er signi¢cantly between the two substrate pairs. Com-
pared with the other enzymes, rf9a had the highest selectivity
for arginine. The in£uence of residue 190 was comparable in
all enzymes and for both substrate pairs: the selectivity forT
ab
le
1
K
in
et
ic
pa
ra
m
et
er
s
fo
r
th
e
hy
dr
ol
ys
is
of
a
se
ri
es
of
pe
pt
id
e
su
bs
tr
at
es
by
rT
ry
Se
r/
A
la
19
0,
rX
Y
a
Se
r/
A
la
19
0
an
d
rf
10
a
A
la
/S
er
19
0
Su
bs
tr
at
e
rT
ry
Se
r1
90
(W
T
)
rT
ry
A
la
19
0
rX
ya
Se
r1
90
(W
T
)
rX
Y
a
A
la
19
0
rf
10
a
A
la
19
0
(W
T
)
rf
10
a
Se
r1
90
(P
4)
P
3
P
2
P
1
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
k c
at
(s
3
1
)
K
M
(W
M
)
k c
at
/K
M
(s
3
1
W
M
3
1
)
S-
24
44
P
yr
o-
G
lu
-
G
ly
-
A
rg
-
pN
A
18
4.
1
15
9.
7
1.
15
28
1.
3
38
8.
1
0.
72
47
.3
37
.8
1.
25
95
.0
13
7
0.
69
^a
^
0.
03
10
^
^
0.
01
51
S-
22
22
B
z-
Il
e-
G
lu
-
G
ly
-
A
rg
-
pN
A
13
8.
0
57
.5
2.
40
23
3.
2
10
9.
1
2.
14
43
.5
16
.3
2.
67
11
3.
1
91
1.
24
95
.8
14
9
0.
64
45
59
.7
23
0
0.
25
92
C
hr
t-
P
A
M
S-
D
-P
he
-
G
ly
-
A
rg
-
pN
A
16
7.
6
30
.4
5.
51
21
1.
4
51
.0
4.
15
46
.3
9.
3
4.
96
13
0.
5
40
3.
25
12
1.
3
38
5
0.
31
52
72
.0
49
1
0.
14
65
C
hr
X
M
O
C
-
D
-N
le
-
G
ly
-
A
rg
-
pN
A
15
7.
5
32
.7
4.
82
19
2.
6
56
.4
3.
42
54
.3
13
.2
4.
12
13
3.
5
50
2.
66
16
3.
0
20
9
0.
77
88
99
.9
25
1
0.
39
82
C
hr
U
B
z-
L
-A
la
-
G
ly
-
A
rg
-
pN
A
91
.6
13
2.
3
0.
69
14
6.
1
41
2.
9
0.
35
38
.0
49
.2
0.
77
88
.0
17
5
0.
50
29
.3
47
5
0.
06
16
34
.0
13
15
0.
02
58
C
hr
T
ry
C
B
-
V
al
-
G
ly
-
A
rg
-
pN
A
10
3.
0
53
.9
1.
91
12
3.
7
12
1.
0
1.
02
32
.9
12
.4
2.
65
69
.6
41
1.
71
59
.8
63
9
0.
09
36
58
.0
15
25
0.
03
80
C
hr
P
K
B
z-
P
ro
-
P
he
-
A
rg
-
pN
A
11
.2
15
0.
5
0.
07
14
.4
35
2.
9
0.
04
32
.0
69
.8
0.
46
62
.0
26
3
0.
24
11
.1
96
5
0.
01
15
6.
0
13
27
0.
00
45
C
hr
G
K
D
-V
al
-
C
H
A
-
A
rg
-
pN
A
30
.4
11
0.
0
0.
28
61
.6
33
0.
1
0.
19
58
.8
38
.5
1.
53
10
7.
6
15
8
0.
68
35
.1
10
67
0.
03
29
37
.2
23
43
0.
01
59
C
hr
T
H
T
os
-
G
ly
-
P
ro
-
A
rg
-
pN
A
10
6.
7
16
.5
6.
48
14
5.
8
30
.8
4.
74
35
.6
23
.5
1.
51
82
.3
92
0.
89
71
.8
20
3
0.
35
34
56
.3
33
6
0.
16
73
C
hr
P
L
T
os
-
G
ly
-
P
ro
-
L
ys
-
pN
A
19
.1
13
.5
1.
42
27
.0
13
7.
8
0.
20
70
.0
11
6.
0
0.
60
32
.2
63
3
0.
05
37
.7
96
6
0.
03
91
11
1.
5
18
20
0.
06
13
S-
22
66
D
-V
al
-
L
eu
-
A
rg
-
pN
A
26
.6
13
9.
0
0.
19
67
.0
60
3.
7
0.
11
27
.1
11
7.
8
0.
23
80
.5
64
2
0.
13
^
^
0.
01
87
36
.8
38
59
0.
00
95
S-
22
51
D
-V
al
-
L
eu
-
L
ys
-
pN
A
11
.6
49
9.
1
0.
02
33
5.
18
21
76
.0
0.
00
24
75
.2
11
33
0.
06
63
57
.9
14
03
0
0.
00
41
^
^
0.
00
02
1
^
^
0.
00
05
4
B
z,
be
nz
yl
;
C
B
,
ca
rb
ob
en
zo
xy
;
C
H
A
,
cy
cl
oh
ex
yl
al
an
yl
;
M
O
C
,
m
et
ho
xy
ca
rb
on
yl
;
M
S,
m
et
hy
ls
ul
fo
ny
l;
T
os
,
t,
to
sy
l.
a
K
M
w
as
to
o
hi
gh
fo
r
th
es
e
en
zy
m
e^
su
bs
tr
at
e
co
m
bi
na
ti
on
s.
T
he
re
fo
re
,
it
w
as
no
t
po
ss
ib
le
to
de
te
rm
in
e
k c
at
an
d
K
M
in
di
vi
du
al
ly
.
FEBS 26661 9-10-02
K. Sichler et al./FEBS Letters 530 (2002) 220^224 221
arginine was approximately 5.5-fold higher in the Ala190 en-
zymes than in the Ser190 enzymes.
This result indicates that the in£uence of the Q-hydroxyl of
Ser190 on substrate binding is conserved in all enzymes exam-
ined. The hydrogen bond with Ser190 is the only direct inter-
action of P1-lysine with the protein matrix, while P1-arginine
is also stabilised via a salt bridge of its guanidinium group
with the carboxylate of Asp189 at the bottom of the S1 site
[9].
The di¡erences in initial selectivity are caused by di¡erent
binding a⁄nities in the S2^S4 binding sites. With poor canon-
ical substrate recognition in the S2^S4 sites, the substrate
binding and catalysis are dictated by the S1 site, explaining
the stronger dependence on the P1 residue. Therefore, in the
case of rTry, rXYa and rf10a, the arginine preference is stron-
ger with the VLX substrate pair than with the tGPX pair
which employs the conformationally and entropically favour-
able proline in P2. In the case of rf9a, the substrate binding is
almost exclusively dictated by the S1^P1 interaction which
causes a 34^40-fold preference for arginine over lysine, inde-
pendent from the P2^P4 residues.
For rTry, rXYa and rf10a the kinetic parameters kcat and
KM were determined separately. Consistent with all substrates,
the 190 mutation always caused an increase of the KM values.
This indicates that, independent of the resulting overall activ-
ity of the enzyme, each wild-type possesses a S1 site optimised
for substrate binding. In particular, the weakened substrate
binding to rf10a-A190S, which allows for an additional hy-
drogen bond within the S1 pocket, demonstrates that yet un-
identi¢ed subtle e¡ects govern the S1^P1 recognition.
Furthermore, in each enzyme the KM values were higher
with the lysine substrate of a given substrate pair than with
the arginine counterpart. This is in accordance with the work-
ing hypothesis that P1-arginine is bound more tightly and
therefore has a lower KM value than P1-lysine.
The kcat values depended on the combination of residue 190
and the P1 residue. With P1-lysine, they were higher in the
Ser190 variants, while with P1-arginine they were higher in the
Ala190 enzymes. In the Ala190 enzymes, P1-lysine is stabilised
only via hydrophobic interactions and a water bridge with
Asp189. This is probably not su⁄cient to accurately position
the scissile bond in the active site. The hydrogen bond of P1-
lysine with Ser190 is necessary for correct positioning and
e⁄cient turnover of the substrate. The opposite may be true
for P1-arginine: it is possible that in the presence of Ser190 it
is bound too tightly in a non-optimal position. Release of this
restraint in Ala190 could introduce the £exibility necessary for
e⁄cient catalysis. With rTry we observed an exception to this
rule: kcat with tGPK was higher in rTry Ala190 than in rTry
Ser190. Since KM for tGPK in rTry Ser190 approximates the
low KM of tGPR, it is possible that it is necessary to release
the tight binding for e⁄cient catalysis.
3.4. rf9a has a very high speci¢city towards arginine in P1
rf9a di¡ers from all other investigated enzymes. Its amido-
lytic activity is three to seven orders of magnitude lower than
that of rf10a, rXYa and rTry. Anomalously high KM values
mostly explain the low reactivity of rf9a. In fact, the KM
values are higher than the solubility of the associated sub-
strates. Therefore, we could only determine the speci¢city
constants kcat/KM of rf9a, but not the detailed kinetic param-
eters kcat and KM (Table 3). Compared with the other en-
zymes, rf9a displays an up to 18-fold higher selectivity of
arginine over lysine in P1, for both the Ser190 wild-type
and the Ala190 mutant enzyme. Finally, rf9a is the only en-
zyme where the mutant (Ala190) has a two-fold higher activ-
ity towards arginine-containing substrates than the wild-type
enzyme.
Previous investigations linked factor IXa’s low amidolytic
activity to its 99 loop. The loop hinders substrate binding to
the S2^S4 sites, thus causing factor IXa’s high KM values
[12,13,16]. The high selectivity towards arginine in P1 is pre-
sumably a direct consequence of the poor substrate binding to
rf9a’s S2^S4 sites. The relative contribution of the S1^P1
binding energy to the total substrate binding is much higher
in the case of rf9a than in the other enzymes, and similarly the
di¡erence in binding energy of P1-arginine versus P1-lysine is
more signi¢cant. In addition to the dominating contribution
of the primary speci¢city pocket in rf9a, the relatively high
selectivity for P1-arginine may also re£ect the intrinsic partic-
ularities of its architecture and function. In particular, Glu219
is strictly conserved in the S1 site of factor IXa, while other
trypsin-like serine proteases have Gly at this position. The
conformation of this residue is favourable only to Gly. Con-
sistent with this, the point mutation G219E in rf10a destabi-
lised the S1 pocket [12]. When compared to lysine, the more
Table 2
Change of the kinetic parameters of rTy Ser190CAla190, rXYa Ser190CAla190 and rf10a Ala190CSer190 with a series of peptide substrates
represented by the ratios of the kinetic parameters
Substrate rTry mutant/WT rXYa mutant/WT rf10a mutant/WT
(P4) P3 P2 P1 kcat KM kcat/KM kcat KM kcat/KM kcat KM kcat/KM
S-2444 Pyro- Glu- Gly- Arg- pNA 1.53 2.43 0.63 2.01 3.64 0.55 ^ ^ 0.49
S-2222 Bz-Ile- Glu- Gly- Arg- pNA 1.69 1.90 0.89 2.60 5.62 0.46 0.62 1.55 0.40
Chr t-PA MS- D-Phe- Gly- Arg- pNA 1.26 1.68 0.75 2.82 4.31 0.65 0.59 1.28 0.46
Chr X MOC- D-Nle- Gly- Arg- pNA 1.22 1.72 0.71 2.46 3.81 0.65 0.61 1.20 0.51
Chr U Bz- L-Ala- Gly- Arg- pNA 1.60 3.12 0.51 2.32 3.55 0.65 1.16 2.77 0.42
Chr Try CB- Val- Gly- Arg- pNA 1.20 2.25 0.53 2.11 3.28 0.64 0.97 2.39 0.41
Chr PK Bz- Pro- Phe- Arg- pNA 1.28 2.34 0.55 1.94 3.77 0.51 0.54 1.38 0.39
Chr GK D-Val- CHA- Arg- pNA 2.03 3.00 0.68 1.83 4.09 0.45 1.06 2.20 0.48
Chr TH Tos- Gly- Pro- Arg- pNA 1.37 1.87 0.73 2.31 3.92 0.59 0.78 1.66 0.47
Chr PL Tos- Gly- Pro- Lys- pNA 1.41 10.25 0.14 0.46 5.45 0.08 2.96 1.89 1.57
S-2266 D-Val- Leu- Arg- pNA 2.52 4.34 0.58 2.97 5.45 0.55 ^ ^ 0.51
S-2251 D-Val- Leu- Lys- pNA 0.45 4.36 0.10 0.77 12.38 0.06 ^ ^ 2.64
Average change with arginine in P1 1.57 2.47 0.66 2.34 4.14 0.57 0.79 1.80 0.45
For abbreviatons see Table 1.
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rigid side chain of arginine may be better suited to stabilise
the S1 pocket of rf9a by an induced ¢t mechanism. In addi-
tion, the guanidinium group of arginine, but not the terminal
amino group of lysine, is able to interact with the carbonyl of
Glu219, again stabilising the S1 pocket. The latter interaction
will further contribute to correctly position the substrate for a
productive turnover.
The detailed analysis of the activity enhancement of rf9a-
S190A towards P1-arginine substrates would require tracking
the changes in the individual kinetic parameters, which was
impossible in the case of rf9a. By analogy with the other
studied enzymes, one would assume that the mutant rf9a-
S190A has increased KM values, and kcat values dependent
on the P1 residue, i.e. increased kcat for P1-arginine and de-
creased kcat for P1-lysine. Given the kinetic peculiarities of
rf9a, additional mechanisms may superimpose these depend-
ences.
3.5. The activity enhancement of rf9a-S190A re£ects an
evolutionary relation to rf10a
The coagulation enzymes factor IXa and factor Xa are
evolutionarily closely related. Despite the large di¡erences in
the absolute reactivities of these enzymes, this relation is re-
£ected by their parallel change in activity dependent on Ala/
Ser at position 190 of the enzyme and Arg/Lys at P1. The
Ala190 variant of either enzyme is twice as active as the re-
spective Ser190 variant towards the P1-arginine substrate,
while the Ala190 activity towards P1-lysine substrates is re-
duced by a factor of two (Table 3). Moreover, Ser190 in
factor IXa is encoded by TCN, not AGY. This observation
is in line with the notion that residue 190 is evolutionarily
related by single site mutations to Ala190 in factor Xa, en-
coded by GCC [2].
The natural substrates of both factor IXa and Xa have
arginine in P1 exclusively. Ala190, the more active variant,
is conserved in factor Xa in all species. By contrast, factor
IXa has a strictly conserved Ser190, which confers only half
the activity of Ala190. Given the low absolute activity of
factor IXa, the activity reduction caused by Ser190 is rela-
tively modest. Nevertheless, Ser190 emphasises the evolution-
ary optimisation of factor IXa towards an enzyme which is
hardly active in the absence of its cofactor and correct sub-
strate. Ser190 may represent a choke, which is released only in
the Xase complex. This underlines factor IXa’s critical role in
the blood coagulation cascade.
3.6. Substrate preference in dependence on Ser/Ala190 is
universally conserved in serine proteases
rXYa combines properties of rf10a with those of trypsin
[11]. In particular, both the S1 and S4 substrate recognition
sites are derived from both factor Xa (His57, Asp102; Tyr99)
and trypsin (Ser195, Ser190; 170^175 loop). Notably, the bi-
factorial S1^P1 dependence, re£ected by the approximately
¢ve-fold selectivity enhancement for arginine versus lysine
P1 residues in the presence of Ala190 versus Ser190, resembles
that of evolutionarily optimised enzymes (P1 selectivity col-
umns in Table 3). This invariance of the selectivity contrasts
with the otherwise smoothened activity pro¢le (Table 1) [11],
which is caused by the hybrid nature of important substrate
binding sites. The robustness of the identi¢ed cross-depen-
dence even in an engineered hybrid enzyme emphasises its
universal conservation within the serine protease family.T
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3.7. Biotechnological implications
The conserved cross-dependence allows us to predict the
e¡ect of a Ser/Ala substitution in position 190 on the P1-
arginine over P1-lysine preference. While we now understand
how to engineer an approximately ¢ve-fold improved arginine
speci¢city in the S1 site of any serine protease (introduction of
Ala190), additional mutations will be necessary to reverse the
speci¢city towards a preference for lysine. In particular, we
propose that in addition to introduction of Ser190 it would be
necessary to block binding of P1-arginine and enable direct
P1-lysine interaction with the protein matrix, e.g. by introduc-
tion of a glutamate at position 189.
The engineering of proteases with enhanced speci¢city can
be valuable for example in the biotechnological production of
peptides from precursor proteins, because loss due to unspe-
ci¢c cleavage can be minimised and the downstream puri¢ca-
tion simpli¢ed.
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